New Zealand markets open in 7 hours 38 minutes

Zoetis Inc. (ZTS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
200.33-1.63 (-0.81%)
At close: 04:04PM EST
200.33 0.00 (0.00%)
After hours: 07:37PM EST

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees11,300

Key executives

NameTitlePayExercisedYear born
Ms. Kristin C. PeckCEO & Director2.79M3.07M1971
Mr. Glenn C. DavidGroup Pres & Exec. VP1.53M3.81M1972
Ms. Wafaa MamilliExec. VP and Chief Information & Digital Officer2.6MN/A1967
Mr. Roman TrawickiExec. VP and Pres of Global Manufacturing & Supply2.19M1.45M1964
Mr. Wetteny N. JosephExec. VP & CFON/AN/A1972
Ms. Roxanne LaganoExec. VP and Chief HR Officer & Global OperationsN/AN/A1965
Mr. Steven FrankVP of Investor RelationsN/AN/AN/A
Ms. Heidi C. ChenExec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health DiagnosticsN/AN/A1967
Mr. William PriceVP & Chief Communications OfficerN/AN/AN/A
Mr. Timothy J. BettingtonExec. VP & Pres of U.S. OperationsN/AN/A1974
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, blood glucose monitors, and laboratory services; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate governance

Zoetis Inc.’s ISS governance QualityScore as of 26 September 2021 is 6. The pillar scores are Audit: 4; Board: 1; Shareholder rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.